Neil M. Iyengar, MD
Breast Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Associate Attending Physician
I am a medical oncologist and clinical investigator with a practice dedicated exclusively to the care of patients with breast cancer. As a member of our multidisciplinary team of specialists, I treat patients with an individualized and multifaceted approach based on cutting-edge technology and the most up-to-date research.
My practice is focused on providing patients with state-of-the-art care plans using advanced technologies and innovative strategies to treat breast cancer while also providing support for general well-being, such as nutrition and exercise. Ultimately, I am dedicated to providing clear communication and understandable information regarding standard therapies as well as new and exciting research options so that patients are empowered to make informed decisions about their care.
Read more
My research investigates the links between metabolic health and cancer. I work with a highly productive team composed of clinical and laboratory scientists at Memorial Sloan Kettering, Weill Cornell Medical College, and the Rockefeller University, where I hold a joint research position. Our team has established inflammation in the breast to be a key contributor to obesity-related breast cancers. As obesity rates are on the rise in the United States and worldwide, we are seeing an increase in obesity-related cancers. We have shown that inflammation in the fatty tissue of the breast and at other anatomic sites occurs in most obese and overweight individuals and even in some individuals who are normal weight. Therefore a key component of my research program is the development of clinical trials — including diets, exercise, and medications — that aim to prevent obesity-related cancers as well as improve outcomes in patients with fatty-tissue inflammation.
A breast medical oncologist is a cancer doctor who specializes in breast cancer.
My Specialties
- Breast Cancer
- Exercise Oncology
Education
- MD, University of Illinois at Chicago
Residencies
- Internal Medicine - University of Chicago Medical Center
Awards and Honors
- Chemotherapy Foundation Symposium Oncology Hero Award, Physicians Education Resource (2023)
- Career Development Award, Conquer Cancer the ASCO Foundation
- Breast Cancer Research Foundation Investigator
- The Society of MSK Research Grant
- Young Investigator Award, Conquer Cancer the ASCO Foundation
- Breast Cancer Achievement Award, Lynn Sage Breast Cancer Symposium
- Young Investigator Award, Expedition Inspiration
- Merit Award, Conquer Cancer the ASCO Foundation
Fellowships
- Oncology/Hematology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Iyengar sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Odessa M. Williams. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.
Clinical Trials
- Clinical Trials Investigated by Dr. Iyengar
- A Phase II Study of Evexomostat plus Eribulin for People with Triple-Negative Breast Cancer
- Clinical Trials Co-Investigated by Dr. Iyengar
- A Study Assessing the Effect of Aerobic Exercise on Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Iyengar’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Neil M. Iyengar discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
Becton, Dickinson and Company
Professional Services and Activities -
Novartis
Professional Services and Activities
-
Pfizer, Inc.
Professional Services and Activities -
Seagen
Professional Services and Activities -
TerSera Therapeutics LLC
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].